Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-11-18

FDA Approved: IPRATROPIUM BROMIDE — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved Apotex Corp.'s supplemental application for ipratropium bromide (generic) under ANDA 076155. The approval concerns a supplemental filing for this g…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE)

Snippet

SUPPL AP for IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE)